WASHINGTON - Market competition is preferable for holding down costs of medications to that of opening up the U.S. borders to importation of drugs from Canada and other foreign nations or imposing price controls, like is done in Europe, said Rep. Henry Waxman (D-Calif.). (BioWorld Today)